Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD
Clinical trial NCT04247594 · TERMINATED
Trial details
- NCT number
- NCT04247594
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2021-06-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.